Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från IRLAB Therapeutics via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2023-06-01 07:00:00
Gothenburg, Sweden, June 1, 2023 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will participate at Redeye Growth Day 2023 on Thursday, June 1, 2023, in Stockholm, Sweden.
Nicholas Waters, EVP and Head of R&D, and Viktor Siewertz, CFO, will participate in the event. The company will be presented at 16:05-16:30 CET on June 1, 2023. This event is held at Haymarket by Scandic, Hötorget 13-15, Stockholm, and is live-streamed.
More information can be found on the event webpage at: https://www.redeye.se/events/871323/redeye-growth-day?tab=abouttheevent.